Genetic association studies in diabetic nephropathy

Current Diabetes Reviews

Volumn 8, Issue 5, 2012, Pages 336-344

  Gu, Harvest F ^a   Brismar, Kerstin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes; Diabetic nephropathy; End stage renal disease; Epigenetics; Genetic association; Microsatellite; Next generation sequencing; Single nucleotide polymorphism; Type

Indexed keywords

MICROSATELLITE DNA;

DIABETIC NEPHROPATHY; EPIGENETICS; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX DISTRIBUTION;

EID: 84866662705     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/157339912802083522     Document Type: Review

References (53)

1. Shields J, Maxwell AP. Managing diabetic nephropathy. Clin Med.2010 10(5):500-4.
2. Weil EJ, Curtis JM, Hanson RL, Knowler WC, Nelson RG. Theimpact of disadvantage on the development and progression ofdiabetic kidney disease. Clin Nephrol. 2010 74 Suppl 1:S32-8.
3. Thomas MC, Groop PH. New approaches to the treatment ofnephropathy in diabetes. Expert Opin Investig Drugs. 201120(8):1057-71.
4. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS. Segregationanalysis of urinary albumin excretion infamilies with type 2 diabetes. Diabetes. 2000 49(6):1057-63.
5. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assessment of familial clustering of diabeticnephropathy in type 1 diabetes. Diabetes. 2004 53(9):2449-54.
6. Pitkäniemi J, Moltchanova E, Haapala L, Harjutsalo V, TuomilehtoJ, Hakulinen T. Genetic random effects model for family data withlong-term survivors: analysis of diabetic nephropathy in type 1diabetes. Genet Epidemiol. 2007 31(7):697-708.
7. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stagerenal disease. Kidney Int Suppl. 2005 94:S46-9.
8. http://www.ncbi.nlm.nih.gov/projects/SNP/
9. http://www.hgvbaseg2p.org
10. http://projects.tcag.ca/variation/
11. http://hapmap.ncbi.nlm.nih.gov/
12. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, RothschildCB, Akots G, Rich SS, Freedman BI. Linkage of genetic markerson human chromosomes 20 and 12 to NIDDM in Caucasian sibpairs with a history of diabetic nephropathy. Diabetes. 46(5):882-6.1997.
13. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, KrolewskiAS. Major susceptibility locus for nephropathy in type 1 diabeteson chromosome 3q: results of novel discordant sib-pair analysis. Diabetes. 47(7):1164-9. 1998.
14. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes formicrovascular complications among Pima Indians with type 2diabetes. Pima Diabetes Genes Group. Diabetes. 47(5):821-30.1998.
15. Bowden DW, Colicigno CJ, Langefeld CD, et al. genome scan fordiabetic nephropathy in African Americans. Kidney Int. 66:1517-26, 2004.
16. Chistiakov DA, Savost'anov KV, Shestakova MV, etal. Confirmation of a susceptibility locus for diabetic nephropathyon chromosome 3q23-q24 by association study in Russian type 1diabetic patients. Diabetes Res Clin Pract. 66:79-86, 2004.
17. Freedman BI, Bowden DW, Sale MM, Langefeld CD, Rich SS. Genetic susceptibility contributes to renal and cardiovascularcomplications of type 2 diabetes mellitus. Hypertension. 48:8-13,2006.
18. Osterholm AM, He B, Pitkaniemi J, et al. Genome-wide scan fortype 1 diabetic nephropathy in the Finnish population reveals suggestivelinkage to a single locus on chromosome 3q. Kidney Int.71:140-5, 2007.
19. McKnight AJ, Maxwell AP, Sawcer S, et al. A genome-wide DIABETICNEPHROPATHYA microsatellite association screen toidentify chromosomal regions harboring candidate genes in diabeticnephropathy. J Am Soc Nephrol. 17:831-6, 2006
20. Cox NJ, Hayes MG, Roe CA, Tsuchiya T. Bell GI. Linkage ofcalpain 10 to type 2 diabetes: the biological rationale. Diabetes.2004 53 Suppl 1:S19-25.
21. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the geneencoding calpain-10 is associated with type 2 diabetes mellitus. NatGenet. 2000 26(2):163-75.
22. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcriptionfactor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006 38(3):320-3.
23. Hayden PS, Iyengar SK, Schelling JR, Sedor JR. Kidney disease, genotype and the pathogenesis of vasculopathy. Curr Opin NephrolHypertens. 2003 12(1):71-8.
24. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence fordifferent susceptibility genes for proteinuria and ESRD in type 2diabetes. Adv Chronic Kidney Dis. 2005 12(2):155-69.
25. Ma J, Möllsten A, Prázny M, et al. Genetic influences of theintercellular adhesion molecule 1 (ICAM-1) gene polymorphismsin development of Type 1 diabetes and diabetic nephropathy. Diabet Med. 2006 23(10):1093-9.
26. Zhang D, Efendic S, Brismar K, Gu HF. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development ofnephropathy in type 1 Diabetes Mellitus. BMC Med Genet. 201011:116.
27. Greene CN, Keong LM, Cordovado SK, Mueller PW. Sequencevariants in the PLEKHH2 region are associated with diabeticnephropathy in the GoKinD study population. Hum Genet. 2008124(3):255-62.
28. Gumprecht J, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E. Angiotensin I-converting enzyme geneinsertion/deletion and angiotensinogen M235T polymorphisms:risk of chronic renal failure. End-Stage Renal Disease StudyGroup. Kidney Int. 2000 58(2):513-9.
29. Billings LK, Florez JC. The genetics of type 2 diabetes: what havewe learned from GWAS? Ann N Y Acad Sci. 2010 1212:59-77.
30. Hanson RL, Craig DW, Millis MP, et al. Identification of PVT1 asa candidate gene for end-stage renal disease in type 2 diabetesusing a pooling-based genome-wide single nucleotidepolymorphism association study. Diabetes. 2007 56(4):975-83.
31. Maeda S, Osawa N, Hayashi T, Tsukada S, Kobayashi M, KikkawaR. Genetic variations associated with diabetic nephropathy andtype II diabetes in a Japanese population. Kidney Int Suppl. 2007106:S43-8.
32. Pezzolesi MG, Poznik GD, Mychaleckyj JC. Genome-wideassociation scan for diabetic nephropathy susceptibility genes intype 1 diabetes. Diabetes. 2009 58(6):1403-10.
33. Craig DW, Millis MP, DiStefano JK. Genome-wide SNPgenotyping study using pooled DNA to identify candidate markersmediating susceptibility to end-stage renal disease attributed toType 1 diabetes. Diabet Med. 2009 26(11):1090-8.
34. McDonough CW, Palmer ND, Hicks PJ, et al. A genome-wideassociation study for diabetic nephropathy genes in AfricanAmericans. Kidney Int. 2011 79(5):563-72.
35. Pezzolesi MG, Skupien J, Mychaleckyj JC, Warram JH, KrolewskiAS. Insights to the genetics of diabetic nephropathy through agenome-wide association study of the GoKinD collection. SeminNephrol. 2010 30(2):126-40.
36. Maeda S, Araki S, Babazono T, et al. Replication study for theassociation between four Loci identified by a genome-wideassociation study on European American subjects with type 1diabetes and susceptibility to diabetic nephropathy in Japanesesubjects with type 2 diabetes. Diabetes. 2010 59(8):2075-9.
37. Freedman BI, Hicks PJ, Bostrom MA, et al. Non-muscle myosinheavy chain 9 gene MYH9 associations in African Americans withclinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant. 2009 24(11):3366-71.
38. Lin CP, Adrianto I, Lessard CJ, et al. Gaffney PM, MontgomeryCG. Role of MYH9 and APOL1 in African and non-Africanpopulations with lupus nephritis. Genes Immun. 2011 doi:10.1038/gene.2011.82.
39. Cooke JN, Bostrom MA, Hicks PJ, et al. Polymorphisms in MYH9are associated with diabetic nephropathy in European Americans. Nephrol Dial Transplant. 2011 Oct 3. [Epub ahead of print]
40. Kao WH, Klag MJ, Meoni LA, et al. Family Investigation ofNephropathy and Diabetes Research Group. MYH9 is associatedwith nondiabetic end-stage renal disease in African Americans. NatGenet. 2008 40(10):1185-92.
41. Freedman BI, Langefeld CD, Lu L, et al. Differential effects ofMYH9 and APOL1 risk variants on FRMD3 Association withDiabetic ESRD in African Americans. PLoS Genet. 20117(6):e1002150.
42. Silbiger SR, Neugarten J. The role of gender in the progression ofrenal disease. Adv Ren Replace Ther. 2003 10:3-14.
43. Fried LF, Katz R, Cushman M, et al. Change in CardiovascularRisk Factors with Progression of Kidney Disease. Am J Nephrol.2008 29:334-41.
44. Dahlquist G, Möllsten A, Källén B. Swedish Childhood DiabetesStudy Group. Hospitalization for vascular complications inchildhood onset type 1 diabetes--effects of gender and age at onset. Acta Paediatr. 2008 97:483-8.
45. Pettersson-Fernholm K, Frojdo S, Fagerudd J, Tomas MC, Forsblom C. for the FinnDiane study group. The AT2 gene mayhave a gender-specific effect on kidney function and pulse pressurein type 1 diabetic patients. Kid Int 2006 69:1880-4.
46. Gu HF, Alvarsson A, Efendic S, Brismar K. SOX2 Has Gender-Specific Genetic Effects on Diabetic Nephropathy in SamplesFrom Patients With Type 1 Diabetes Mellitus in the GoKinDStudy. Gender Medicine 2009 6:555-564.
47. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR;UKPDS Study Group. Risk factors for renal dysfunction in type 2diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 200655(6):1832-9.
48. Sapienza C, Lee J, Powell J, et al. DNA methylation profilingidentifies epigenetic differences between diabetes patients withESRD and diabetes patients without nephropathy. Epigenetics.2011 6(1):20-8.
49. Villeneuve LM, Natarajan R. The role of epigenetics in thepathology of diabetic complications. Am J Physiol Renal Physiol.2010 299(1):F14-25.
50. Brennan EP, Ehrich M, O'Donovan H, et al. DNA methylationprofiling in cell models of diabetic nephropathy. Epigenetics. 20105(5):396-401.
51. Lehne B, Lewis CM, Schlitt T. Exome localization of complexdisease association signals. BMC Genomics. 2011 12:92.
52. Bonnefond A, Durand E, Sand O, et al. Molecular diagnosis ofneonatal diabetes mellitus using next-generation sequencing of thewhole exome. PLoS One. 2010 5(10):e13630.
53. Majewski J, Schwartzentruber J, Lalonde E, Montpetit A, JabadoN. What can exome sequencing do for you? J Med Genet. 201148(9):580-9.